AcoArt Litos PCB Below-the-knee Global Trial

Part of paid clinical trials in Concord, California.

Sponsor
Acotec Scientific Co., Ltd
Study ID
NCT06330493
Status
Recruiting

Conditions

  • Chronic Limb-Threatening Ischemia

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • PCB — DEVICE
    Paclitaxel coated PTA balloon catheter
  • PTA — DEVICE
    Non-coated FDA cleared (US) or CE-marked (EU) standard percutaneous transluminal angioplasty balloon catheter

Study Details

The objective of this study is to assess whether efficacy of the AcoArt Litos PCB is superior and whether safety of AcoArt Litos PCB is noninferior to the control device (FDA cleared PTA Balloon Catheter) regarding treatment of obstructions in the infrapopliteal arteries (located distal to the P3 segment of the popliteal artery and extending to the tibiotalar joint) in patients presenting with chronic limb-threatening ischemia (CLTI)(Rutherford 4-5)

Key Dates

Start date
Oct 10, 2025
Status verified
Jun 2026
Primary completion
Oct 31, 2028
Completion
Oct 31, 2032

Study Design

Enrollment
288 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: PCB Group
    use PCB catheter(trade name: AcoArt Litos) to treat the stenosis or occlusion in infrapopliteal artery of experimental arm
  • Active Comparator: PTA Group
    use standard PTA balloon catheter to treat stenosis or occlusion in infrapopliteal artery of control group

Primary Outcome Measure

Primary Efficacy Endpoint: Composite of freedom from major amputation and primary patency [ Time Frame: 12 months ]

Central Contacts

Locations (17)

FacilityCityStateZIPSite coordinators
John Muir HealthConcordCalifornia94520
Rita Trachuk
Wayland Lim, MD (PRINCIPAL_INVESTIGATOR)
California Cardiovascular Consultants and Medical AssociatesFremontCalifornia94545
Ashit Jain, MD (PRINCIPAL_INVESTIGATOR)
Yale School of MedicineNew HavenConnecticut06519
Carlos Mena-Hurtado, MD (PRINCIPAL_INVESTIGATOR)
Miami Vascular CenterHialeahFlorida33012
Keyttia Sardinas, Clinical Research Coordinator
305-822-0068
Pablo Guala, MD (PRINCIPAL_INVESTIGATOR)
First Coast Cardiovascular InstituteJacksonvilleFlorida32255
Amy Suphachinda, Clinical Research Manager
(904) 493-3333
Yazan Khatib, MD (PRINCIPAL_INVESTIGATOR)
Midwest Cardiovascular Research FoundationDavenportIowa52801-
American Endovascular and Amputation Prevention (AEAP)OrangeNew Jersey92868
Jas Kaur
347-944-4694
Mahmood Razavi, MD (PRINCIPAL_INVESTIGATOR)
Kevin Herman, MD (PRINCIPAL_INVESTIGATOR)
Columbia University/NYPHNew YorkNew York10032
Kate Dalton
347-514-3366
Sahil Parikh, MD, PhD (PRINCIPAL_INVESTIGATOR)
Cornell UniversityNew YorkNew York10065
Maureen Dominguez
646-962-3826
Christopher Agrusa, MD (PRINCIPAL_INVESTIGATOR)
South Charlotte General & Vascular SurgeryCharlotteNorth Carolina28278
Alexis LeMieux, Clinical Research Coordinator
253-307-6290
James Antezana, MD (PRINCIPAL_INVESTIGATOR)
Cleveland ClinicClevelandOhio44195-0001
Mary Alice Bowman
216-440-6561
Aravinda Nanjundappa, MD (PRINCIPAL_INVESTIGATOR)
Miriam HospitalProvidenceRhode Island02906
Lina Felix, Clinical Research Coordinator
401-793-4105
Peter Soukas, MD (PRINCIPAL_INVESTIGATOR)
Ballad Health CVA Heart InstituteKingsportTennessee37660
Terrie Walker
423-230-5643
Chris Metzger, MD (PRINCIPAL_INVESTIGATOR)
Clements University Hospital (UTSW)DallasTexas75390
Kathryn Naumann, Clinical Research Director
214-648-7200
Michael Siah, MD (PRINCIPAL_INVESTIGATOR)
Baylor Scott & White Research Institute (BSW)Fort WorthTexas76104
Kristina Perez
Mohammad Alqaim, MD (PRINCIPAL_INVESTIGATOR)
North Dallas Research Associates (NDRA)McKinneyTexas75069-
Sunrise VascularDanvilleVirginia24541
Alexis LeMieux, Clinical Research Coordinator
(253) 307-6290
Sreejit Nair, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Concord, CA

Related Studies